0001140361-16-067949.txt : 20160531 0001140361-16-067949.hdr.sgml : 20160531 20160531185217 ACCESSION NUMBER: 0001140361-16-067949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160526 FILED AS OF DATE: 20160531 DATE AS OF CHANGE: 20160531 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 161687459 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1245 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc1.xml FORM 4 X0306 4 2016-05-26 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001197355 FUCHS HENRY J C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, Chief Medical Officer Common Stock 2016-05-26 2016-05-26 4 M 0 15000 26.49 A 130914 D Common Stock 2016-05-26 2016-05-26 4 S 0 10000 88.04 D 120914 D Common Stock 2016-05-26 2016-05-26 4 S 0 5000 87.34 D 115914 D Common Stock (Right to buy Common Stock) 26.49 2016-05-26 2016-05-26 4 M 0 15000 0 D 2011-11-12 2021-05-11 Common Stock 15000 65225 D All shares were sold at the same price The price in column 4 is a weighed average price. The price actually received ranged from $86.50 to $88.34. The reporting person will provide to the issuer, and security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Reflects the number of stock options outstanding after the transaction from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2016-05-31